MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

eye disease

  • Ozempic Users Face Double Risk of Rare Vision Loss, Nordic Studies Find
    Ozempic Users Face Double Risk of Rare Vision Loss, Nordic Studies Find
    Despite the findings, researchers cautioned against the immediate cessation of Ozempic treatment.
    December 25, 2024BY George Citroner
  • Antioxidant Supplement Could Slow Progression of Blinding Eye Disease
    Antioxidant Supplement Could Slow Progression of Blinding Eye Disease
    AREDS2 supplements require caution, despite promising results, experts warn.
    August 24, 2024BY George Citroner
  • Seeing Clearly: Gut-Related Problems Affect the Eyes
    Seeing Clearly: Gut-Related Problems Affect the Eyes
    With links to the gut, several eye diseases could potentially be prevented or treated by restoring microbiome homeostasis.
    August 24, 2024BY Amy Denney
  • Scientists Discover New Method to Prevent Age-Related Vision Loss
    Scientists Discover New Method to Prevent Age-Related Vision Loss
    Boosting a protein linked to aging protects against age-related macular degeneration.
    June 30, 2024BY Huey Freeman
  • Increased Incidents of Eye Disease Occurring in the Vaccinated: Texas Optometrist
    Increased Incidents of Eye Disease Occurring in the Vaccinated: Texas Optometrist
    An optometrist in Houston, Texas, is seeing an increase in incidents of eye disease in patients who opted ...
    March 7, 2024BY Matt McGregor
  • First Case of White Dot Syndrome Emerged After COVID-19 Vaccine and Subsequent Infection, Study Shows
    First Case of White Dot Syndrome Emerged After COVID-19 Vaccine and Subsequent Infection, Study Shows
    Scientists from New Zealand have uncovered the first case of a rare eye disease linked to both the ...
    September 10, 2023BY Mary Gillis
  • Common Eye Disease Among Older People Could Pose Serious Risk of COVID-19, Study Says
    Common Eye Disease Among Older People Could Pose Serious Risk of COVID-19, Study Says
    A recent study suggests that people with age-related macular degeneration, a common eye condition, could be at greater ...
    January 4, 2023BY Bill Pan
  • What Your Eyes Reveal About Your Health
    What Your Eyes Reveal About Your Health
    Scientists at the University of California, San Diego, have developed a smartphone app that can detect early signs ...
    September 25, 2022BY Barbara Pierscionek
  • One in Three People Has This Eye Parasite
    One in Three People Has This Eye Parasite
    It can damage your vision, be harmful during pregnancy and may not initially cause symptoms. Take these steps ...
    June 21, 2022BY Joseph Mercola
TOP NEWS
  • FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
    1hr By Kimberly Hayek
    FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
  • Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
    2hr By Travis Gillmore
    Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
  • 124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
    3hr By Arthur Zhang
    124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
  • Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
    3hr By Epoch Video
    Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
  • The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
    3hr By Sheramy Tsai
    The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
  • Senate Panel Advances Bill to Make Hospitals Compete on Price
    4hr By Lawrence Wilson
    Senate Panel Advances Bill to Make Hospitals Compete on Price
  • House Adopts Budget Blueprint for $95 Billion Reconciliation Package
    5hr By Jackson Richman
    House Adopts Budget Blueprint for $95 Billion Reconciliation Package
  • House Passes Congressional Stock Trading Ban
    5hr By Jackson Richman and Nathan Worcester
    House Passes Congressional Stock Trading Ban
  • US Signs Nuclear Cooperation Deal With Saudi Arabia
    5hr By Emel Akan
    US Signs Nuclear Cooperation Deal With Saudi Arabia
  • Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
    6hr By Jack Phillips
    Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top